N-(2-氰基-3-氟苯基)吡咯 | 148901-51-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 中文名称: N-(2-氰基-3-氟苯基)吡咯
• 英文名称: 2-Fluoro-6-pyrrol-1-yl-benzonitrile
• 英文别名: 2-Fluoro-6-(1h-pyrrol-1-yl)benzonitrile；2-fluoro-6-pyrrol-1-ylbenzonitrile
• CAS: 148901-51-3
• 化学式: C₁₁H₇FN₂
• 分子量: 186.188
• InChiKey: NPZSWZGYPPDMFS-UHFFFAOYSA-N

物化性质

• 熔点：
  67 °C
• 沸点：
  328.2±32.0 °C(Predicted)
• 密度：
  1.14±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  28.7
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S23,S36,S37,S39
• 危险类别码：
  R10
• 海关编码：
  2933990090
• 危险品运输编号：
  UN 3275

反应信息

• 作为反应物：
  描述：

  N-(2-氰基-3-氟苯基)吡咯 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 18.0h， 生成 4-(4-Ethyl-phenyl)-7-fluoro-5,6-dihydro-4H-benzo[f]pyrrolo[1,2-a][1,4]diazepine
  参考文献：
  名称：

  Pyrrolo[1,2-a][1,4]benzodiazepine: A novel class of non-azole anti-dermatophyte anti-fungal agents

  摘要：

  Broad screening revealed compound la to be a novel anti-fungal agent with high specificity towards dermatophytes. The anti-fungal structure-activity relationship of this novel class of 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzodiazepines is described together with its mode of action that appeared to be the inhibition of squalene epoxidase. Preliminary in vivo results of the most active compounds are also reported. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.05.007
• 作为产物：
  描述：

  吡咯 、 2,6-二氟苯腈 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以51%的产率得到N-(2-氰基-3-氟苯基)吡咯
  参考文献：
  名称：

  [EN] NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
  [FR] NOUVELLES 5,6-DIHYDRO-4H-PYRROLO-[1,2-A][1,4]BENZODIAZÉPINES ET 6H-PYRROLO[1,2-A][1,4]BENZODIAZÉPINES ANTIFONGIQUES SUBSTITUÉES PAR DES DÉRIVÉS BICYCLIQUES DU BENZÈNE

  摘要：

  本发明涉及一种新型抗真菌5,6-二氢-4H-吡咯- [1,2-a][1,4]苯并二氮杂环和6H-吡咯- [1,2-a][1,4]苯并二氮杂环，其被取代为公式（I）中的双环苯衍生物，其中R1，R2，R3，R4，R5，R6和R7具有权利要求中定义的含义。根据本发明的化合物主要对抗皮肤癣和系统性真菌感染具有活性。该发明还涉及制备这种新型化合物的工艺、含有该化合物作为活性成分的药物组合物以及将该化合物用作药物的用途。

  公开号：

  WO2012084804A1

文献信息

• [EN] (AZA)PYRIDOPYRAZOLOPYRIMIDINONES AND INDAZOLOPYRIMIDINONES AS INHIBITORS OF FIBRINOLYSIS<br/>[FR] (AZA)PYRIDOPYRAZOLOPYRIMIDINONES ET INDAZOLOPYRIMIDINONES UTILISÉES COMME INHIBITEURS DE LA FIBRINOLYSE
  申请人：BAYER PHARMA AG

  公开号：WO2015067549A1

  公开（公告）日：2015-05-14

  The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.

  本申请涉及新型取代的(氮杂)吡啶吡唑吡嘧啶酮和吲唑吡嘧啶酮，以及它们的制备方法，这些化合物可单独或组合使用于治疗和/或预防疾病的方法中，特别是用于治疗和/或预防患有或不患有基础遗传或获得性出血性疾病的患者的急性和复发性出血，其中出血与来自以下组中选择的疾病或医疗干预相关，该组包括月经过多、产后出血、出血性休克、创伤、手术、移植、中风、肝病、遗传性血管性水肿、鼻血、以及血液积聚后的滑膜炎和软骨损伤。
• (Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20150126449A1

  公开（公告）日：2015-05-07

  The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.

  本申请涉及新型取代的(氮杂)吡啶吡唑吡嘧啶酮和吲唑吡嘧啶酮，以及它们的制备方法，这些化合物可单独或组合使用于治疗和/或预防疾病的方法中，特别是用于治疗和/或预防患有或不患有基础遗传或获得性出血性疾病的患者的急性和复发性出血，其中出血与来自月经过多、产后出血、出血性休克、创伤、手术、移植、中风、肝病、遗传性血管性水肿、鼻血和血液性关节积血后的滑膜炎和软骨损伤等疾病或医疗干预有关。
• Synthesis of Diaryl Ethers, Diaryl Thioethers, and Diarylamines Mediated by Potassium Fluoride−Alumina and 18-Crown-6:  Expansion of Scope and Utility¹
  作者：J. Scott Sawyer、Elisabeth A. Schmittling、Jayne A. Palkowitz、William J. Smith

  DOI：10.1021/jo980800g

  日期：1998.9.1

  An efficient alternative to the Ullmann ether synthesis of diaryl ethers, diaryl thioethers, and diarylamines involving the SNAr addition of a phenol, thiophenol, or aniline to an appropriate aryl halide, mediated by potassium-fluoride alumina and 18-crown-6 in acetonitrile or DMSO, is described. Expansion of the reaction conditions to include DMSO as solvent has resulted in a far greater range of substitution patterns permitted on the electrophile. For example, it was found that electronically unfavorable S-chlorobenzonitrile could be condensed with 3-methoxyphenol to form the corresponding diaryl ether in 66% yield, a combination not normally amenable to Ullmann coupling. Electron-withdrawing groups present on the electrophile may be as diverse as nitro, cyano, formyl, acetyl, ester, amide, and even aryl. The method features a simple reaction procedure that provides products in generally good to excellent purified yields.
• Synthesis of diaryl ethers, diaryl thioethers, and diarylamines mediated by potassium fluoride-alumina and 18-crown-6
  作者：Elisabeth A. Schmittling、J. Scott Sawyer

  DOI：10.1021/jo00064a004

  日期：1993.6

  An efficient alternative to the copper-catalyzed synthesis (Ullmann ether synthesis) of diaryl ethers, diaryl thioethers, and diarylamines involving the potassium fluoride-alumina-mediated addition of a phenol, thiophenol, or an aniline to 2- or 4-fluorobenzonitriles catalyzed by 18-crown-6 is described.
• NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
  申请人：Janssen Pharmaceutica, N.V.

  公开号：EP2668187B1

  公开（公告）日：2014-10-15